The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.

Guests

  • Richard Pierce professor of administrative law at George Washington University
  • Dr. Mitchell Creinin physician
  • Maxine Klane Planned Parenthood of Metropolitan Washington

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Dec 19 2014World leaders react to a historic shift in U.S. policy toward Cuba. Pakistan buries victims of a school massacre by the Taliban. And U.S. officials say North Korea is behind the hacking of Sony Pictures. A panel of journalists joins Diane for analysis of the week's top international news stories.

The Future Of U.S.-Cuban Relations

Thursday, Dec 18 2014Cuba releases American contractor Alan Gross after five years' imprisonment on espionage charges. The U.S. releases several Cubans in exchange. Details on the prisoner swap and the future of U.S.-Cuban relations.